Meridian Bioscience Inc. Stock
-
Your prediction
Meridian Bioscience Inc. Stock
Pros and Cons of Meridian Bioscience Inc. in the next few years
Pros
Cons
Performance of Meridian Bioscience Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Meridian Bioscience Inc. | - | - | - | - | - | - | - |
| SI-BONE Inc | -0.890% | -4.310% | 4.717% | -11.200% | -34.320% | - | - |
| Lantheus Holdings Inc | 0.280% | 0.701% | 11.008% | -19.830% | 25.524% | -7.043% | - |
| Lemaitre Vascular Inc | -2.040% | -1.538% | 0.000% | 21.519% | 36.170% | - | - |
Comments
News
Atlas Energy Stock Jumps 39% YTD, but One Fund Cut Exposure by $15 Million Last Quarter
On February 17, 2026, Meridian Wealth Advisors disclosed a reduction in its Atlas Energy Solutions (NYSE:AESI) position, selling 1,458,193 shares for an estimated $14.74 million based on average
This REIT Is Down 60% Since 2006, but a $9.2 Million Bet Says There’s Still Value
New York City-based DSC Meridian Capital initiated a new position in Elme Communities (NYSE:ELME), acquiring 543,081 shares valued at approximately $9.2 million, according to a November 14 SEC
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
New York City-based DSC Meridian Capital fully exited its position in Bausch + Lomb during the third quarter, reducing its holdings by 510,090 shares, a move totaling approximately $6.6 million.


